Engineering Stimuli‐Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy
2020 · Advanced Materials · 143 citations
https://doi.org/10.1002/adma.201907210
Z
Zhiai Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
6.4K
Citations
47
h-index
116
i10-index
Zhiai Xu is an academic researcher from Guangdong University of Technology. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Advanced biosensing and bioanalysis techniques & Electrochemical sensors and biosensors. The author has an h-index of 47, co-authored 132 publications.
ORCID: 0000-0002-4391-2507Papers by this author
worksAcid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer
2022 · Advanced Materials · 110 citations
https://doi.org/10.1002/adma.202209910
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
2020 · Nano Today · 72 citations
https://doi.org/10.1016/j.nantod.2020.101025
Near infrared light-actuated gold nanorods with cisplatin–polypeptide wrapping for targeted therapy of triple negative breast cancer
2015 · Nanoscale · 65 citations
https://doi.org/10.1039/c5nr03693c
Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
2021 · Advanced Materials · 63 citations
https://doi.org/10.1002/adma.202102668
Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy
2023 · Nature Communications · 61 citations
https://doi.org/10.1038/s41467-023-39035-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat